Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–6 of 6 results
Advanced filters: Author: Robert J. Ragotte Clear advanced filters
  • The combination of computational design, laboratory-based screening and biophysical validation enables the de novo generation of variable heavy-chain antibody fragments and antibodies that precisely target chosen disease-related molecules.

    • Nathaniel R. Bennett
    • Joseph L. Watson
    • David Baker
    ResearchOpen Access
    Nature
    P: 1-11
  • Antibodies can have synergistic effects, but mechanisms are not well understood. Here, Ragotte et al. identify three antibodies that bind neighbouring epitopes on CyRPA, a malaria vaccine candidate, and show that lateral interactions between the antibodies slow dissociation and inhibit parasite growth synergistically.

    • Robert J. Ragotte
    • David Pulido
    • Simon J. Draper
    ResearchOpen Access
    Nature Communications
    Volume: 13, P: 1-12
  • Deep learning methods have been used to design proteins that can neutralize the effects of three-finger toxins found in snake venom, which could lead to the development of safer and more accessible antivenom treatments.

    • Susana Vázquez Torres
    • Melisa Benard Valle
    • David Baker
    ResearchOpen Access
    Nature
    Volume: 639, P: 225-231
  • Fine-tuning the RoseTTAFold structure prediction network on protein structure denoising tasks yields a generative model for protein design that achieves outstanding performance on a wide range of protein structure and function design challenges.

    • Joseph L. Watson
    • David Juergens
    • David Baker
    ResearchOpen Access
    Nature
    Volume: 620, P: 1089-1100
  • RH5, which is part of the trimeric RCR-complex essential for invasion, is a vaccine candidate for malaria. Here, Williams et al. show that monoclonal antibodies targeting each of the three proteins in the RCR-complex can work together to more effectively block the invasion of red blood cells by Plasmodium falciparum and design a combination vaccine candidate.

    • Barnabas G. Williams
    • Lloyd D. W. King
    • Simon J. Draper
    ResearchOpen Access
    Nature Communications
    Volume: 15, P: 1-16
  • Structural studies show how the PfRCR complex of Plasmodium falciparum forms a bridge between erythrocyte and parasite membranes, and how PfCyRPA-binding antibodies neutralize invasion through a steric mechanism, opening the way to new approaches in rational vaccine design.

    • Brendan Farrell
    • Nawsad Alam
    • Matthew K. Higgins
    ResearchOpen Access
    Nature
    Volume: 625, P: 578-584